New: a trial court in 1 of every 10 U.S. counties. Read the post
Court Rules
All enforcement actions
SettlementCritical RiskMultistate

Sandoz Generic Drug Price-Fixing Settlement

Sandoz Inc. and Fougera Pharmaceuticals Inc.October 1, 2026Connecticut Attorney General

Penalty Amount

$400,000,000

Summary

Connecticut Attorney General William Tong announced a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. resolving allegations that the generic drug manufacturers conspired to inflate prices, limit competition, and restrain trade. The settlement includes consumer restitution and injunctive reforms; court approval was being sought.

Remedy

Sandoz agreed to pay $400 million in the settlement and to injunctive terms, including internal reforms intended to promote fair competition and compliance with antitrust laws. The settlement provides restitution for eligible consumers who purchased certain generic prescription drugs.

Monetary PenaltyInjunctionCompliance ProgramConsumer Refunds

Contract Impact

This release concerns antitrust conduct, not privacy violations. In supplier, distributor, and customer agreements, review provisions on pricing, market allocation, exchange of competitively sensitive information, benchmarking, and contacts with competitors; ensure they do not facilitate coordination or restrict competition. For employee agreements and policies, review confidentiality and communications rules, antitrust training, escalation procedures, and record-preservation requirements. The release does not identify privacy-specific contract changes.

Contract Search Terms

competitor communicationspricing information exchangemarket allocationcompetitively sensitive informationantitrust compliance representationstrade association participationpricing approval controlsemployee antitrust training

Laws Cited

Antitrust laws

Violation Types

Entity Details

Entity

Sandoz Inc. and Fougera Pharmaceuticals Inc.

Industry

Healthcare

Multistate Coalition

AlaskaArizonaCaliforniaColoradoDelawareDistrict of ColumbiaIdahoIllinoisIndianaIowaKansasKentuckyMaineMarylandMassachusettsMichiganMinnesotaMississippiNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaNorthern Mariana IslandsOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth DakotaTennesseeU.S. Virgin IslandsVermontVirginiaWashingtonWest VirginiaWisconsinWyoming

Official Sources

Source Evidence

Entity Name
"with Sandoz Inc. and Fougera Pharmaceuticals Inc."
Fine Amount
"a $400 million settlement"
Laws Cited
"compliance with antitrust laws"
Violation Types
"engaged in a widespread, long-running conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade"
Is Multistate
"a coalition of 43 states and territories"

Related Enforcement Actions

NY

Sandoz Inc. and Fougera Pharmaceuticals Inc.

$400.0M

New York Attorney General Letitia James and a coalition of 47 other attorneys general secured a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. over an alleged scheme to coordinate generic drug prices and reduce competition. The settlement provides for consumer compensation and requires Sandoz to implement antitrust compliance reforms, including annual staff training and a Chief Compliance Officer.

CO

Sandoz Inc. and Fougera Pharmaceuticals Inc.

$469.0M

Colorado joined a 43-state-and-territory settlement resolving allegations that Sandoz and Fougera participated in a long-running conspiracy to inflate generic drug prices, reduce competition, and restrain trade. The companies agreed to pay approximately $469 million and implement reforms; the states are seeking court approval.

CT

Frontier Communications Parent Inc.

$625K

Connecticut reached a $625,000 settlement with Frontier Communications Parent Inc. over an April 2024 breach in which compromised employee and vendor credentials were used to access internal systems and exfiltrate unencrypted personal information of 58,841 Connecticut residents. The settlement requires Frontier to strengthen its security program, implement specific safeguards and training, and obtain an independent third-party assessment.

CT

Boston Children’s Health Physicians and XTIUM

$2.6M

Connecticut and New York found that Boston Children’s Health Physicians and its security vendor, XTIUM, failed to use reasonable safeguards, resulting in hackers accessing sensitive personal, medical, and employee information. The companies agreed to pay penalties totaling $2.64 million and implement enhanced cybersecurity measures.

CT

Character Technologies, Inc.

Connecticut joined a coalition of state attorneys general filing a notice in Character Technologies, Inc.’s bankruptcy proceedings, raising concerns about the company’s safety and privacy practices and the sensitive information it holds. The states seek protections for children and consumers if the company’s business or assets are sold or transferred; the filing does not impose a fine or other remedy.

CT

Connecticut public utilities

Attorney General William Tong and Consumer Counsel Claire Coleman petitioned PURA to review how Connecticut public utilities use artificial intelligence, citing potential data privacy and cybersecurity risks, algorithmic errors, and misleading outputs. The petition asks PURA to examine utility AI systems, safeguards, vendors, and data security practices; it does not report a finding of violation or an imposed penalty.